FierceBiotechOriginal article
{"a":[{"_":"Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division","$":{"href":"/cro/fortrea-boosts-early-phase-platform-45-million-cro-acquisition","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Fortrea has agreed to acquire the early-phase services division of Worldwide Clinical Trials for $45 million to expand its CRO platform capabilities.
Importance:5/10
Sentiment:
0.50
M&ACROearly-phaseacquisition
Read the original article
Published by FierceBiotech on September 2, 2026 2:48 PM